Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference6%
- Check19 days agoChange DetectedNew entries for Dendritic Cell Tumor and Blastic Plasmacytoid Dendritic Cell have been added, while numerous links related to various lymphomas and genetic conditions have been removed.SummaryDifference1%
- Check26 days agoChange DetectedThe website has been updated to include numerous new links related to genetics and various lymphomas, as well as a new version revision (v2.12.2), replacing the previous version (v2.12.1).SummaryDifference4%
- Check33 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.4%
- Check41 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.9%
- Check55 days agoChange DetectedDifference0.6%
Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.